Organigram Hlds Inc (OGI)
$1.06
0.02 (1.95%)
OGI Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
962,339
Day's Range
1.05 - 1.08
52-Week Range
1.04 - 4.01
Dividend & Yield
N/A (N/A)
OGI Stock Predictions, Articles, and Organigram Hlds Inc News
OrganiGram Is the General Electric of Weed Stocks
OGI stock appeals due to its comeback appeal, especially in the backdrop of Cannabis 2.0. However, market sentiment does not place much hope on this narrative.
Structural Challenges Remain, But Not All Hope Is Lost for OrganiGram Stock
OrganiGram isn't a safe stock by any means. But there is a visible pathway for OGI stock to climb by hundreds of percent.
5 Marijuana Stocks to Buy For A “Blue Wave” Election
Marijuana stocks could rally in a big way if Democrats seize control of the House, Senate and White House in November.
Will OrganiGram Stock Finally Capitalize on Cannabis 2.0?
A return to work and a stake in cannabis derivatives bode well for OrganiGram stock in the long term. Here's what investors should consider.
OrganiGram Earnings: OGI Stock Falls 12% on Q2 Results
OrganiGram (OGI) earnings for the Canadia cannabis company's fiscal second quarter of 2020 have OGI stock taking a hit on Tuesday.
Don’t Lump OrganiGram Stock With All the Other Downtrodden Pot Stocks
Even during a challenging time for the broader canna-business, there are still a few good reasons to hold onto OrganiGram stock.
OrganiGram Stock Highlights the Real Risks and Rewards in Cannabis
For cannabis bulls, OrganiGram stock looks cheap. But the issues plaguing the sector could find their way to OGI stock.
OrganiGram Stock Still Has Explosive Upside Potential in 2020
If you believe things will get better in the Canadian cannabis market, then OGI stock has explosive upside potential from here.
Now’s the Time to Bite into OrganiGram Stock
The rise of Cannabis 2.0 along with a relatively stable business makes OrganiGram stock an interesting buy in the legal marijuana space.
OrganiGram Stock is a Reasonable Cannabis Bet Amid a Sea of Riskier Ones
OrganiGram stock skyrocketed off its fiscal Q1 earnings report but just as quickly came tumbling back down. However, the underlying company is better positioned than most to enjoy a solid year in 2020.
This Is How OrganiGram Stock Could Double in 2020
Pot stocks are rebounding, and OrganiGram stock could be a big winner in this rebound thanks to its relative undervaluation.
Organigram Stock a Standout Long-Term Winner in the Cannabis Sector
With plenty of demand and legalization efforts, the long-term growth story is still very much intact with Organigram stock.
OrganiGram Earnings: OGI Stock Soars 27% on Q1 Earnings Report
OrganiGram (OGI) earnings for the cannabis company's fiscal first quarter of 2020 have OGI stock soaring in after-hours trading on Tuesday.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
